Abstract:Preeclampsia (PE) is a leading cause of maternal and neonatal mortality and morbidity worldwide, impacting the long-term health of both mother and offspring. PE has long been characterized by deficient trophoblast invasion into the uterus and consequent placental hypoperfusion, yet the upstream causative factors and effective interventional targets for PE remain unknown. Alterations in the metabolism of preeclamptic placentas are thought to result from placental ischemia, while disturbances of the metabolism and of metabolites in PE pathogenesis are largely ignored. In fact, as one of the largest fetal organs at birth, the placenta consumes a considerable amount of glucose and fatty acid. Increasing evidence suggests glucose and fatty acid exist as energy substrates and regulate placental development through bioactive derivates. Moreover, recent findings have revealed that the placental metabolism adapts readily to environmental changes, altering its response to nutrients and endocrine signals; this adaptability optimizes pregnancy outcomes by diversifying available carbon sources for energy production, hormone synthesis, angiogenesis, immune activation, and tolerance, and fetoplacental growth. These observations raise the possibility that carbohydrate and lipid metabolism abnormalities play a role in both the etiology and clinical progression of PE, sparking a renewed interest in the interrelationship between PE and metabolic dysregulation. This review will focus on key metabolic substrates and regulatory molecules in the placenta and aim to provide novel insights with respect to the metabolism's role in modulating placental development and functions. Further investigations from this perspective are poised to decipher the etiology of PE and suggest potential therapies.

Iron Metabolism and Ferroptosis in Physiological and Pathological Pregnancy

Iron and copper interactions in development and the effect on pregnancy outcome

Iron Homeostasis During Pregnancy: Maternal, Placental, and Fetal Regulatory Mechanisms

Effect of Low-Iron During Pregnancy on Serum Lipids and Serum Glucose in Adult Offspring Rats

Iron metabolism and ferroptosis: A pathway for understanding preeclampsia

The Protective Effects of Ferrostatin-1 Against Inﬂammation-Induced Preterm Birth and Fetal Brain Injury

Maternal iron supplementation during pregnancy affects placental function and iron status in offspring

Insights into the pathogenesis of gestational and hepatic diseases: the impact of ferroptosis

Iron Metabolism and Brain Development in Premature Infants

The Role of Fe, Zn, and Cu in Pregnancy

Spotlight on iron overload and ferroptosis: Research progress in female infertility

Iron Deficiency and Iron Deficiency Anemia: Implications and Impact in Pregnancy, Fetal Development, and Early Childhood Parameters

Revisiting preeclampsia: a metabolic disorder of the placenta

Marginally reduced maternal hepatic and splenic ferroportin under severe nutritional iron deficiency in pregnancy maintains systemic iron supply

Current research and evidence gaps on placental development in iron deficiency anemia

The Role of Ferroptosis in Placental-Related Diseases

Impact of ferroptosis on preeclampsia: A review

Ferroportin expression and regulation in human placenta/fetal membranes: Implications for ferroptosis and adverse pregnancy outcomes

Association between maternal iron status and the risk of pre-eclampsia: a case-control study

The roles of free iron, heme, haemoglobin, and the scavenger proteins haemopexin and alpha-1-microglobulin in preeclampsia and fetal growth restriction

Ferroptosis in Obstetrical and Gynecological Diseases: A Mini Review